Compare NeoGenomics Inc. Common Stock (NEO) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Sirius XM Holdings Inc — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while Sirius XM Holdings Inc trades at $26.35 (market cap $8.96B). The key difference: Sirius XM Holdings Inc is far larger — about 4.2× NeoGenomics Inc. Common Stock's market cap, and Sirius XM Holdings Inc pays a 4.06% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Sirius XM Holdings Inc for 103 Days on average.
| NEO | SIRI | |
|---|---|---|
Market Cap | $2.14B | $8.96B |
Volume | 2,228,400 | 4,120,955 |
Sector | Health | Media |
52-Week High | $19.91 | $32.59 |
52-Week Low | $7.19 | $19.92 |
Typical Hold Time | 0 Days | 103 Days |
Enterprise Value | $2.44B | $18.24B |
Dividend Yield | — | 4.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Sirius XM Holdings (SIRI) trades at $26.51, down 0.38% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The stock is valued attractively with a P/E of 10.67 and P/B of 0.75, supported by a net income margin of 10.23%. Recent earnings have been volatile, with a beat in Q1 2026 but a miss in Q2 2026. The company's cash flow from operations remains strong at $1.90 billion for 2025, and a recent dividend of $0.27 per share was declared.
The outlook for SIRI is cautiously optimistic, driven by analyst consensus favoring a buy rating (62.5%) and a price target of $34.43, implying significant upside. Key opportunities include growth in subscription revenue and advertising expansion, notably the YouTube partnership. Risks include competitive pressures in the audio entertainment sector and execution challenges in monetizing new initiatives. The stock's current valuation and cash flow generation present a compelling case for investors seeking value in the communication services space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
